News & Blog
-
News
08 October 2018
Ovarian Cancer Action Research Grant Award Ceremony
Last night the Ovarian Cancer Action Research Grant Awards took place at the Royal Society, awarding funds to scientists working to tackle the disease at every level – from screening and early detection to treatment and recurrence.
-
Blog
25 September 2018
"Mum loved pink lipsticks and could never resist buying another shade"
After losing her beloved mum Mary to ovarian cancer in 2009, Jackie Abbott decided to hold a fundraising event in her memory, inspired by Mary's love of pink lipstick! Now in its 7th year, Pink Night has raised over £5,000 for Ovarian Cancer Action. Jackie shares her story.
-
Blog
14 September 2018
"Their generous legacy will now enable research into the diagnosis and treatment of the disease to continue moving forwards"
After losing his wife Linda to ovarian cancer in 2017, Graham Atkinson made the decision to leave a gift to Ovarian Cancer Action in his will. The Atkinsons’ close friend and executor of their will, Jim Edwards, shares their story.
-
News
13 September 2018
Cancer patients in Northern Ireland set to have same access to drugs as the rest of the UK
Cancer patients in Northern Ireland are set to have the same access to drugs as the rest of the UK, the Department of Health has announced.
-
News
12 September 2018
Comment regarding potential urine test for ovarian cancer
Yesterday it was reported that a new urine test for ovarian cancer was on the horizon. We take a closer look at the story.
-
Blog
04 September 2018
An important step forward
An incredible 12,421 of you signed our petition to fund a clinical audit of ovarian cancer — thank you. Marie-Claire Platt, Head of Campaigns at Ovarian Cancer Action, discusses the government's response and what comes next.
-
News
03 September 2018
Call for equal access to Niraparib for women in Northern Ireland
This year the PARP inhibitor Niraparib has been approved for use throughout much of the UK, giving hope to thousands of women with recurrent, platinum-sensitive ovarian cancer. However, it is not yet available in Northern Ireland.
-
News
24 August 2018
Drug combination shows exciting results in ovarian cancer in early trial
A study published recently in the Annals of Oncology and reported by the Institute of Cancer Research has shown exciting results that could offer hope to thousands of women with recurrent, platinum-resistant advanced stage ovarian cancer.
-
News
23 August 2018
First ever NHS ovarian cancer early detection pilot announced
Ovarian Cancer Action is pleased to support the ALDO project; a pilot launched by The UCLH Cancer Collaborative, which aims to establish whether ovarian cancer screening can be feasible and cost effective on the NHS for women with BRCA1 and BRCA2 mutations.
-
Your Stories
16 August 2018
Lesley Torun
Lesley was diagnosed with stage 1b ovarian cancer last year. She shares her experience so far.
-
News
13 August 2018
Exciting new research could lead to personalised ovarian cancer treatments
Patterns of genetic mutation in ovarian cancer are helping make sense of the disease and could be used to personalise treatment in future, according to a study published in Nature Genetics today.
-
News
10 August 2018
Innovative new treatment approved for Scottish ovarian cancer patients
The Scottish Medicine Consortium (SMC) has today approved a drug called Niraparib, providing new hope for women with...
-
Blog
09 August 2018
The CA125 blood test: your questions answered
A CA125 blood test should be requested if a doctor suspects a patient's symptoms could be caused by ovarian cancer.
-
Blog
07 August 2018
Back to the lab, cycling training and old vans
Professor Bob Brown's research focuses on epigenetics and drug resistance – why chemotherapy sometimes stops working for patients with ovarian cancer. Later this year his partner, Justine, will cycle 240 miles from London to Paris over 3 days for Women V Cancer, raising money for three women's cancer charities, including Ovarian Cancer Action. Bob provides an update on the highs and lows of training and his vital ovarian cancer research that Women V Cancer helps to fund.
-
Blog
27 July 2018
Talcum powder: what's the story?
After the latest round of pay-outs Johnson & Johnson have been ordered to pay $4.7bn (£3.6bn) to women who claim their ovarian cancer was caused by using talcum powder. Ovarian Cancer Action investigates the facts behind this on-going legal case.
-
News
26 July 2018
Could regular aspirin use reduce ovarian cancer risk?
There have been a series of reports recently claiming that taking aspirin can play a major role in both preventing ovarian cancer and increasing survival rates in women who already have the disease.
-
News
25 July 2018
10,000 signatures and counting — we did it!
Over the past few months, thousands of you have signed and shared the petition to the UK Government to fund a national clinical audit for ovarian cancer. Thanks to you, the petition has now reached 10,000 signatures, meaning we can expect a government response in due course.
-
Blog
19 July 2018
Cannabis oil and ovarian cancer: the facts
Using cannabis oil as a means to treat or cure cancer is a topic of much online debate and the internet is full of people claiming that it has effectively helped to cure their cancer. We take a closer look at the evidence behind these claims.
-
Blog
18 July 2018
Bloating: your questions answered
People will describe bloating in slightly different ways, but usually, it is the uncomfortable feeling of tightness or distention around the abdomen. It might be accompanied by pain or the increased need to pass wind.
-
Your Stories
16 July 2018
Alan Roberts
Alan Roberts pays tribute to his beloved wife, Carys, who lost her life to ovarian cancer in March this year. A hugely talented artist, the sale of Carys's artwork has left an incredible legacy, helping to raise £25,000 for a number of cancer charities.